Thurston Springer Miller Herd & Titak’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.3K Buy
92
+21
+30% +$5.81K 0.01% 680
2026
Q1
$21K Sell
71
-79
-53% -$23.5K 0.01% 758
2025
Q4
$41K Buy
150
+112
+295% +$30.4K 0.01% 543
2025
Q3
$10.3K Sell
38
-688
-95% -$187K 0.02% 351
2025
Q2
$200K Buy
726
+242
+50% +$65.8K 0.03% 368
2025
Q1
$128K Buy
484
+213
+79% +$52.5K 0.02% 415
2024
Q4
$62.9K Buy
271
+78
+40% +$17.9K 0.01% 478
2024
Q3
$42.6K Buy
193
+74
+62% +$15.3K 0.01% 604
2024
Q2
$23.4K Buy
+119
New +$24.6K 0.01% 773

Other funds holding CME

Thurston Springer Miller Herd & Titak's CME Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its CME Group (CME) stake by 30% in Q2 2026, buying an estimated $5.81K and bringing the position to 92 shares worth $20.3K. The position accounts for 0.01% of the portfolio, ranked #680.

Thurston Springer Miller Herd & Titak first reported a position in CME in Q2 2024 and has held it in 9 quarters since. The position peaked at $200K in Q2 2025. 593 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 92 shares of CME Group worth $20.3K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak bought 21 CME Group shares in Q2 2026, an estimated $5.81K.
  • CME Group made up 0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #680 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in CME Group in Q2 2024 and has held it in 9 quarters since.
  • Thurston Springer Miller Herd & Titak's CME Group position peaked at $200K in Q2 2025.
  • 593 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.